Skip to main content

An update on human interleukin-1: From molecular biology to clinical relevance

Journal of Clinical Immunology volume 5, pages 287–297 (1985)Cite this article

Abstract

Interleukin-1 (IL-1) represents a family of polypeptides with a wide range of biological activities. At least two dissimilar gene products have been cloned; there are probably more. The human IL-1 family plays an important role in the pathogenesis of many diseases and functions as a key mediator of the host response to various infectious, inflammatory, and immunologic challenges. Recombinant mouse (pI 5) and recombinant human (pI 7) IL-1's are being used to confirm the multiple biological properties of IL-1's but considerable investigation is required before the specific activities (biological units per milligram of protein) are established for each human IL-1 form. Some IL-1 biological activities such as the induction of hepatic acute-phase protein synthesis have been demonstrated in invertebrates predating the evolution of lymphocytes. IL-1 is highly inflammatory and increases the concentration of metabolites of arachidonic acid, most notably prostaglandin E2, in brain, muscle, chondrocytes, and synovial fibroblasts. The synthesis of leukotrienes also is involved in the mechanism of its action on certain tissues. The cloning and expression of human IL-1 genes will expand our understanding of IL-1 in various diseases through improved detection systems and the use of cDNA probes; the development of IL-1 antagonists, as well as the use of IL-1 as an immunomodulator, is presently being considered.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. Dinarello CA: Interleukin-1 and the pathogenesis of the acute phase response. N Engl J Med 311:1413–1418, 1984

    Google Scholar 

  2. Gery I, Waksman BH: Potentiation of the T-lymphocyte response to mitogens. J Exp Med 136:143–155, 1972

    Google Scholar 

  3. Dinarello CA, Wolff SM: Molecular basis of fever in humans. Am J Med 72:799–819, 1982

    Google Scholar 

  4. Kampschmidt RF: Infection, inflammation, and interleukin-1. Lymphokine Res 2:97–110, 1984

    Google Scholar 

  5. Krane SM, Goldring SR, Dayer J-M: Interactions among lymphocytes, monocytes and other synovial cells in the rheumatoid synovium.In Lymphokines, E Pick, M Landy (eds). New York, Academic Press, 1982, Vol 7, pp 75–95

    Google Scholar 

  6. Dinarello CA: Interleukin-1. Rev Infect Dis 6:51–95, 1984

    Google Scholar 

  7. Saklatvala J, Pilsworth LMC, Sarsfield SJ, Gavrilovic J, Heath JK: Pig catabolin is a form of interleukin-1. Biochem J 224:461–466, 1984

    Google Scholar 

  8. DiSilvestero RA, Cousins RJ: Induction of rat metallothionein by interleukin-1. J Leuk Biol 37:697, 1985

    Google Scholar 

  9. Baracos V, Rodemann HP, Dinarello CA, Goldberg AL: Stimulation of muscle protein degradation by leukocytic pyrogen (interleukin-1). N Engl J Med 308:553–558, 1983

    Google Scholar 

  10. Pepys MB, Baltz ML: Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. Adv Immunol 34:141–212, 1983

    Google Scholar 

  11. Ramadori G, Sipe JD, Dinarello CA, Mizel SB, Colten HR: Pretranslational modulation of acute phase hepatic protein synthesis by murine recombinant interleukin-1 and purified human IL-1. J Exp Med (in press)

  12. Gauldie J, Sauder DN, McAdam KPWJ, Dinarello CA: Purified human interleukin-1 stimulates secretion of multiple acute phase proteinsin vitro.In Physiologic, Metabolic and Immunologic Actions of Interleukin-1, MJ Kluger, JJ Oppenheim, MC Powanda (eds). New York, AR Liss, 1985 (in press)

    Google Scholar 

  13. Neufeld HA, Pace JG, Kaminski MV, George DT, Jahrling PB, Wannemacher RW Jr, Beisel WR: A probable endocrine basis for the depression of ketone bodies during infectious or inflammatory state in rats. Endocrinology 107:596–601, 1980

    Google Scholar 

  14. Beisel WR: Metabolic response to infection. Annu Rev Med 16:245–258, 1975

    Google Scholar 

  15. McCarthy DM, Kluger MJ, Vander AJ: Suppression of food intake following endotoxin: Is interleukin-1 involved?In Physiologic, Metabolic and Immunologic Actions of Interleukin-1, MJ Kluger, JJ Oppenheim, MC Powanda (eds). New York, AR Liss, 1985 (in press)

    Google Scholar 

  16. Kreuger JM, Walter J, Dinarello CA, Wolff SM, Chedid L: Sleep-promoting effects of endogenous pyrogen (interleukin-1). Am J Physiol 246:R994-R999, 1984

    Google Scholar 

  17. Kreuger JM, Walter J, Dinarello CA, Chedid L: Induction of slow wave sleep by interleukin-1.In Physiologic, Metabolic and Immunologic Actions of Interleukin-1, MJ Kluger, JJ Oppenheim, MC Powanda (eds). New York, AR Liss, 1985 (in press)

    Google Scholar 

  18. Granstein RD, Margolis S, Mizel, Sauder DN:In vivo chemotatic activity of epidermal cell-derived thymocyte activating factor (ETAF) and interleukin-1 in the mouse. J Leuk Biol 37:709, 1985

    Google Scholar 

  19. Luger TA, Charon JA, Colot M, Micksche M, Oppenheim JJ: Chemotactic properties of partially purified human epidermal cell-derived thymocyte activating factor (ETAF) for polymorphonuclear and mononuclear cells. J Immunol 131:816–820, 1983

    Google Scholar 

  20. Sauder DN, Mounessa NL, Katz SI, Dinarello CA, Gallin JI: Chemotactic cytokines: The role of leukocytic pyrogen and epidermal cell thymocyte-activating factor in neutrophil chemotaxis. J Immunol 132:828–832, 1984

    Google Scholar 

  21. Miossec P, Yu Cl, Ziff M: Lymphocyte chemotactic activity of human interleukin-1. J Immunol 133:2007–2011, 1983

    Google Scholar 

  22. Muraguchi A, Kehrl JH, Butler JL, Fauci AS: Regulation of human B-cell activation, proliferation, and differentiation by soluble factors. J Clin Immunol 4:337–347, 1984

    Google Scholar 

  23. Lipsky PE, Thompson PA, Rosenwasser LJ, Dinarello CA: The role of interleukin-1 in human B cell activation: Inhibition of B cell proliferation and the generation of immunoglobulin secreting cells by an antibody against human leukocytic pyrogen. J Immunol 130:2708–2714, 1983

    Google Scholar 

  24. Mizel SB: Interleukin-1 and T cell activation. Immunol Rev 63:51–72, 1982

    Google Scholar 

  25. Fontana A, Hengartner H, Weber E, Fehr K, Grob PJ, Cohen G: Interleukin-1 activity in the synovial fluid of patients with rheumatoid arthritis. Rheumatol Internat 2:49–53, 1982

    Google Scholar 

  26. Wood DD, Ihrie EJ, Dinarello CA, Cohen PL: Isolation of an interleukin-1-like factor from human joint effusions. Arth Rheumat 26:975–983, 1983

    Google Scholar 

  27. Giulian D, Lachman LB: Interleukin-1 stimulation of astroglial proliferation after brain injury. Science 228:497–499, 1985

    Google Scholar 

  28. Lovett DH, Ryan JL, Sterzel RB: Stimulation of rat mesangial cell proliferation by macrophage interleukin-1. J Immunol 131:2830–2836, 1983

    Google Scholar 

  29. Rossi V, Breviario F, Ghezzi P, Dejana E, Mantovani A: Interleukin-1 induces prostacylclin in vascular cells. Science 229:174–176, 1985

    Google Scholar 

  30. Bevilacqua MP, Pober JS, Majeau GR, Cotran RS, Gimbrone MA Jr: Interleukin-1 induces biosynthesis and cell surface expression of procoagulant activity on human vascular endothelial cells. J Exp Med 160:618–623, 1984

    Google Scholar 

  31. Dunn CJ, Fleming WE: The role of interleukin-1 in the inflammatory response with particular reference to endothelial cell-leukocyte adhesion.In Physiologic, Metabolic and Immunologic Actions of Interleukin-1, MJ Kluger, JJ Oppenheim, MC Powanda (eds). New York, AR Liss, 1985 (in press)

    Google Scholar 

  32. Bevilacqua MP, Pober JS, Wheeler ME, Mendrick D, Cotran RS, Gimbrone MA Jr: Interleukin-1 (IL-1) acts on vascular endothelial cells to increase their adhesivity for blood leukocytes. Fed Proc 44:1494, 1985

    Google Scholar 

  33. Libby P, Wyler DJ, Janicka MW, Dinarello CA: Differential effects of human interleukin-1 on growth of human fibroblasts and vascular smooth muscle cells. Arteriosclerosis 5:186–191, 1985

    Google Scholar 

  34. Libby P, Janicka MW, Dinarello CA: Interleukin-1 promotes production of endothelial cells of activity that stimulates the growth of arterial smooth muscle cells. Fed Proc 44:737, 1985

    Google Scholar 

  35. Habicht GS, Beck G: Inflammation and interleukin-1.In Physiologic, Metabolic and Immunologic Actions of Interleukin-1, MJ Kluger, JJ Oppenheim, MC Powanda (eds). New York, AR Liss, 1985 (in press)

    Google Scholar 

  36. Auron PE, Webb AC, Rosenwasser LJ, Mucci SF, Rich A, Wolff SM, Dinarello CA: Nucleotide sequence of human monocyte interleukin-1 precursor cDNA. Proc Natl Acad Sci USA 81:7907–7911, 1984

    Google Scholar 

  37. Lomedico PT, Gubler U, Hellman CP, Dukovich M, Giri JG, Pan YE, Collier K, Semionow R, Chua AO, Mizel SB: Cloning and expression of murine interleukin-1 inEscherchia coli. Nature 312:458–462, 1984

    Google Scholar 

  38. Dinarello CA, Bernheim HA, Duff GW, Le HV, Nagabhushan TL, Hamilton NC, Coceani F: Mechanisms of fever induced by recombinant human interferon. J Clin Invest 74:906–913, 1984

    Google Scholar 

  39. Lotze MT, Frana LW, Sharrow SO, Robb RJ, Rosenberg SA: In vivo administration of purified human interleukin-2. J Immunol 134:157–166, 1985

    Google Scholar 

  40. Lepe-Zuniga, Gery I: Production of intracellular and extracellular interleukin-1 (IL-1) by human monocytes. Clin Immunol Immunopathol 31:222–230, 1984

    Google Scholar 

  41. Kurt-Jones EA, Beller DI, Mizel SB, Unanue ER: Identification of a membrane-associated interleukin-1 in macrophages. Proc Natl Acad Sci USA 82:1204–1208, 1985

    Google Scholar 

  42. March CJ, Mosley B, Larsen A, Cerretti DP, Braedt G, Price V, Gillis S, Henney CS, Kronheim SR, Grabstein K, Conlon PJ, Hopp TP & Cosman D: Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs.Nature 315:641–646, 1985

    Google Scholar 

  43. Tocci MJ, Shapiro JA, Cameron P, Limjucco G, Rodkey J, Bennett C, Schmidt JA: Molecular biology of normal human interleukin-1. Fed Proc 44:785, 1985

    Google Scholar 

  44. Dinarello CA, Goldin NP, Wolff SM: Demonstration and characterization of two distinct human leukocytic pyrogens. J Exp Med 139:1269–1381, 1974

    Google Scholar 

  45. Murphy PA, Cebula TA, Windle BE: Heterogeneity of rabbit endogenous pyrogens is not attributable to glycosylated variants of a single polypeptide chain. Infect Immun 34:184–191, 1981

    Google Scholar 

  46. Dinarello CA, Renfer L, Wolff SM: Human leukocytic pyrogen: Purification and development of a radioimmunoassay. Proc Natl Acad Sci USA 74:4623–4627, 1977

    Google Scholar 

  47. Dinarello CA, McAdam KPWJ, Rosenwasser LJ: Acute phase protein inducing and lymphocyte activating properties of human leukocytic pyrogen. Clin Res 29:484A, 1981

    Google Scholar 

  48. Lachman LB: Purification of human interleukin-1. Fed Proc 42:2639–2643, 1984

    Google Scholar 

  49. Krakauer T: Structural analysis of the charge heterogeneity of human interleukin-1. Arch Biochem Biophys 23:371–376, 1984

    Google Scholar 

  50. Sauder DN: Epidermal cytokines: Properties of epidermal cell derived thymocyte activating factor. Lymphokine Res 3:145–151, 1984

    Google Scholar 

  51. Wood DD, Bayne EK, Goldring MB, Gowen M, Hamerman D, Humes JL, Ihrie EJ, Lipsky PE, Staruch MJ: The four biochemically distinct species of human interleukin-1 all exhibit similar biologic activities. J Immunol 134:895–892, 1985

    Google Scholar 

  52. Hanson DF, Murphy PA: Demonstration of interleukin-1 activity in apparently homogeneous specimens of the pI 5 form of rabbit endogenous pyrogen. Infect Immun 45:483–490, 1984

    Google Scholar 

  53. Matsushima K, Durum SK, Kimball ES, Oppenheim JJ: Purification of human interleukin-1 and identity of thymocyte co-mitogenic factor, fibroblast proliferation factor, acute phase protein inducing factor, and endogenous pyrogen. Cell Immunol (in press)

  54. Dinarello CA, Bernheim HA, Cannon JG, LoPreste G, Warner SJC, Webb AC, Auron PE: Purified 35-S-methionine, 3-H-leucine labelled human monocyte interleukin-1 with endogenous pyrogen activity. Br J Rheumatol 24:59–64, 1985

    Google Scholar 

  55. Saklatvala J, Sarsfield SJ: Purification to homogeneity of two IL-1-like proteins from pig leukocytes.In Physiologic, Metabolic and Immunologic Actions of Interleukin-1, MJ Kluger, JJ Oppenheim, MC Powanda (eds). New York, AR Liss, 1985 (in press)

    Google Scholar 

  56. Simon PL, Green CL, Lee JC (1985). Preparation and biological activities of a goat IgG antibody to human pI 6.8 interleukin-1.In Physiologic, Metabolic and Immunologic Actions of Interleukin-1, MJ Kluger, JJ Oppenheim, MC Powanda (eds) New York, AR Liss, 1985 (in press)

    Google Scholar 

  57. Van Damme J, De Ley M, Opdenakker G, Billiau A, De Somer P: Homogeneous interferon-inducing 22K factor is related to endogenous pyrogen and interleukin-1. Nature 314:266–268, 1985

    Google Scholar 

  58. Dinarello CA, Clowes GAH Jr, Gordon Savaris C, Wolff SM: Cleavage of human interleukin-1: isolation of a fragment isolated from the plasma of febrile humans and monocytes. J Immunol 133:1322–1338, 1984

    Google Scholar 

  59. Cannon JG, Dinarello CA: Increased plasma interleukin-1 activity in women after ovulation. Science 227:1247–1249, 1985

    Google Scholar 

  60. Kimball ES, Pikeral SF, Oppenheim JJ, Rossio JL: Interleukin-1 activity in normal human urine. J Immunol 133:256–261, 1984

    Google Scholar 

  61. Cannon JG, Dinarello CA: Biological properties of putative interleukin-1 fragments in human plasma. J Leuk Biol 37:689, 1985

    Google Scholar 

  62. Clowes GHA Jr, George BC, Villee CA Jr, Saravis CA: Muscle proteolysis induced by a circulating peptide in patients with sepsis or trauma. N Engl J Med 308:545–552, 1983

    Google Scholar 

  63. Kimball ES, Rossio JL, Dinarello CA: Absence of pyrogenicity by urinary IL-1 activity. Br J Rheumatol 24:42–46, 1985

    Google Scholar 

  64. Gordon AH, Parker ID: A pyrogen derived from human white cells which is active in mice. Br J Exp Pathol 61:534–539, 1980

    Google Scholar 

  65. Gowen M, Wood DD, Ihrie EJ, Meats JE, Russell RGG: Stimulation by human interleukin-1 of cartilage breakdown and production of collagenase and proteoglycanase by human chrondrocytes but not human osteoblastsin vitro. Biochim Biophys Acta 797:186–193, 1984

    Google Scholar 

  66. Liao Z, Grimshaw RS, Rosenstreich DL: Identification of a specific interleukin-1 inhibitor in the urine of febrile patients. J Exp Med 159:126–136, 1984

    Google Scholar 

  67. Dayer J-M, Balavoine J-F, Cruchaud A, de Rochemonteix B: Collagenase and PGE2 stimulating activity (interleukin-1-like) and inhibitor(s) in human urine.In Physiologic, Metabolic and Immunologic Actions of Interleukin-1, MJ Kluger, JJ Oppenheim, MC Powanda (eds). New York, AR Liss, 1985 (in press)

    Google Scholar 

  68. Cannon JG: Is interleukin involved in homeostasis?In Physiologic, Metabolic and Immunologic Actions of Interleukin-1, MJ Kluger, JJ Oppenheim, MC Powanda (eds). New York, AR Liss, 1985 (in press)

    Google Scholar 

  69. Scala G, Kuang YD, Hall RE, Muhmore AV, Oppenheim JJ: Accessory cell function of human B cells. I. Production of both interleukin-1-like activity and an interleukin-1 inhibitory factor by an EBV-transformed human B cell line. J Exp Med 159:1637–1652, 1984

    Google Scholar 

  70. Drabik M, Pasulka P, LoPreste G, Moldawer LL, Dinarello CA, Bistrian BB, Blackburn GL:In vitro measurement of lymphocyte activating factor in hospitalized protein calorie malnourished patients. J Leuk Biol 37:698, 1985

    Google Scholar 

  71. Dempsey RA, Dinarello CA, Mier JW, Rosenwasser LJ, Allegretta M, Brown TE, Parkinson DL: The differential effects of human leukocytic pyrogen/lymphocyte activating factor, T cell growth factor and interferon on human natural killer cell activity. J Immunol 129:2504–2510, 1982

    Google Scholar 

  72. Matsushima K, Onozaki K, Benzur M, Oppenheim JJ: Interleukin-1 as a potential anti-tumor factor.In Physiologic, Metabolic and Immunologic Actions of Interleukin-1, MJ Kluger, JJ Oppenheim, MC Powanda (eds). New York, AR Liss, 1985 (in press)

    Google Scholar 

  73. Herman J, Kew MC, Rabson AR: Defective interleukin-1 production by monocytes from patients with malignant diseases: Interferon increases IL-1 production. Cancer Immunol Immunother 16:182–185, 1984

    Google Scholar 

  74. Dinarello CA, Marnoy SO, Rosenwasser: Role of archidonate metabolism in the immunoregulatory function of human leukocytic pyrogen/lymphocyte activating factor/interleukin-1. J Immunol 130:890–895, 1983

    Google Scholar 

  75. Dinarello CA, Bishai I, Rosenwasser LJ, Coceani F: The influence of lipoxygenase inhibitors in the in vitro production of human leukocytic pyrogen and lymphocyte activating activity (interleukin-1). Int J Immunopharm 6:43–50, 1984

    Google Scholar 

  76. Atkins E: Fever: The old and the new. J Infect Dis 149:339–346, 1984

    Google Scholar 

Download references

Author information

Affiliations

  1. Department of Medicine, Division of Experimental Medicine, Tufts University School of Medicine and the New England Medical Center, 02111, Boston, Massachusetts

    Charles A. Dinarello

Authors
  1. Charles A. Dinarello
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Dinarello, C.A. An update on human interleukin-1: From molecular biology to clinical relevance. J Clin Immunol 5, 287–297 (1985). https://doi.org/10.1007/BF00918247

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00918247

Key words

  • Recombinant interleukin-1
  • acute-phase response
  • lymphocyte activation
  • inflammation